Future Family launched a nationwide IVF insurance product on Wednesday. If families don't achieve a live birth after two cycles of IVF, they can get their money back.
Christina will be part of the panel: "Investor Perspective: What's Hot What's Not". In this session you will hear from a panel of investment leaders from different healthcare industry sectors about the current investment climate. Learn about their strategic priorities and get advice on how startup founders can best succeed in fundraising.
Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird Bio for about $29 million. Meanwhile, Pfizer continued the culling of its gene therapies with the discontinuation of Beqvez for hemophilia B.
Hospitals are adopting AI technology more than ever before, but they still face challenges when it comes to measuring the impact of these solutions and scaling them, noted Kiran Mysore, chief data & analytics officer at Sutter Health.
Blood centers are neutral partners, as they do not compete with hospitals for patients. Instead, they complement hospitals by providing a focused array of high-quality, specialized, patient-centric services, allowing hospitals to maintain primary relationships with patients and their families.
No comments